{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:00:53Z","timestamp":1790470853951,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cllc.2017.03.009","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T18:57:29Z","timestamp":1489690649000},"page":"675-681.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis"],"prefix":"10.1016","volume":"18","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela K.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2017.03.009_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2017.03.009_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1378\/chest.12-2580","article-title":"Stereotactic body radiation therapy for lung cancer","volume":"143","author":"Simone","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2017.03.009_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.6004\/jnccn.2015.0155","article-title":"Stereotactic radiotherapy versus surgery for early-stage operable lung cancer: more questions than answers","volume":"13","author":"Verma","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.cllc.2017.03.009_bib5","first-page":"172","article-title":"Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy","volume":"3","author":"Simone","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cllc.2017.03.009_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.30375","article-title":"Multi-institutional experience of stereotactic body radiotherapy for large (\u22655 centimeters) non-small cell lung tumors","volume":"123","author":"Verma","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2017.03.009_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2016.11.049","article-title":"Influence of fractionation scheme and tumor location on toxicities after stereotactic body radiation therapy for large (\u22655 cm) non-small cell lung cancer: a multi-institutional analysis","volume":"97","author":"Verma","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.03.009_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2016.09.036","article-title":"Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (\u22655 centimeter) non-small cell lung cancer","volume":"97","author":"Verma","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.03.009_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1634\/theoncologist.2015-0348","article-title":"Stereotactic radiotherapy for stage I small cell lung cancer","volume":"21","author":"Verma","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.cllc.2017.03.009_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.prro.2012.10.003","article-title":"Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer","volume":"3","author":"Videtic","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.cllc.2017.03.009_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jrr\/rrs075","article-title":"Clinical results of stereotactic body radiotherapy for stage I small-cell lung cancer: a single institutional experience","volume":"54","author":"Shioyama","year":"2013","journal-title":"J\u00a0Radiat Res"},{"key":"10.1016\/j.cllc.2017.03.009_bib13","first-page":"285","article-title":"Stereotactic body radiation therapy for stage I small cell lung cancer: a single institutional case series and review of the literature","volume":"3","author":"Ly","year":"2014","journal-title":"J\u00a0Radiat Oncol"},{"key":"10.1016\/j.cllc.2017.03.009_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrclinonc.2015.65","article-title":"Lung cancer: implementing lung-cancer screening\u2014oncological \u201cgrey areas\u201d","volume":"12","author":"Verma","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cllc.2017.03.009_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijrobp.2015.03.036","article-title":"Treatment costs of early-stage lung cancers detected by low-dose computed tomography screening","volume":"93","author":"Verma","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.03.009_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jamaoncol.2015.2165","article-title":"Medicare approves coverage for lung cancer screening: the case for symptomatic screening","volume":"1","author":"Verma","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2017.03.009_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2017.03.009_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2016.10.041","article-title":"Multi-institutional experience of stereotactic ablative radiation therapy for stage I small cell lung cancer","volume":"97","author":"Verma","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.03.009_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2015.63.8171","article-title":"Role of adjuvant therapy in a population-based cohort of patients with early-stage small-cell lung cancer","volume":"34","author":"Yang","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2017.03.009_bib20","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2015.07.243","article-title":"Multi-institutional retrospective study of stereotactic body radiation therapy for stage I small cell lung cancer: Japan Radiation Oncology Study Group (JROSG)","volume":"93","author":"Shioyama","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.03.009_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lungcan.2016.11.009","article-title":"Trends in stereotactic body radiation therapy for stage I small cell lung cancer","volume":"103","author":"Stahl","year":"2017","journal-title":"Lung Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730417300864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730417300864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:07:29Z","timestamp":1761505649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730417300864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1525730417300864"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2017.03.009","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2017.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}